Adaptimmune stock plunges after announcing Nasdaq delisting plans
Investing.com - TD Cowen lowered its price target on KeyCorp (NYSE:KEY) to $19.00 from $21.00 on Monday while maintaining a Hold rating on the stock. According to InvestingPro data, the stock currently trades at a P/E ratio of 19.6x and offers a substantial 4.8% dividend yield, having maintained dividend payments for 54 consecutive years.
The firm cited M&A risk as a key factor for its cautious stance, despite acknowledging strong fundamentals in KeyCorp’s recent performance.
KeyCorp posted strong third-quarter 2025 results that reflected solid top-line performance and an improved guidance outlook, according to TD Cowen.
The bank showed momentum building across its fundamentals with a clearer path toward a 13-15% return on tangible common equity (ROTCE), the firm noted.
TD Cowen explained its Hold rating stems from the "door remaining open for bank M&A" combined with KeyCorp "not having a strong currency" despite the encouraging quarterly results.
In other recent news, KeyCorp reported its third-quarter 2025 earnings, surpassing analysts’ expectations with an earnings per share of $0.41, compared to the forecasted $0.38. Revenue also exceeded predictions, reaching $1.9 billion against the expected $1.88 billion. Despite the positive results, investor concerns about future challenges were noted. Additionally, DA Davidson has lowered its price target for KeyCorp to $21 from $22, maintaining a Buy rating, while Jefferies reduced its target to $18 from $20, keeping a Hold rating. Both firms acknowledged KeyCorp’s strong third-quarter performance, with DA Davidson highlighting increased full-year revenue guidance and Jefferies noting net interest margin expansion. These recent developments reflect the mixed sentiment among analysts regarding KeyCorp’s future prospects.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.